Europe Electrophysiology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Electrophysiology Ablation Catheters, Electrophysiology Laboratory Devices, Electrophysiology Diagnostic Catheters, Access Devices, and Others) and Indication [Atrial Fibrillation (AF), Atrial Flutter, Wolff-Parkinson White Syndrome (WPW), Atrioventricular Nodal Reentry Tachycardia (AVNRT), and Others]
The Europe electrophysiology market is expected to grow from US$ 2,398.85 million in 2022 to US$ 4,234.94 million by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.
According to the World Health Organization (WHO), cardiovascular disease (CVD) is one of the leading causes of death across the region. Family history, ethnicity, age, tobacco use, high blood pressure (hypertension), high cholesterol, lack of exercise, unhealthy diet, alcohol consumption, and diseases such as dyslipidemia, obesity, and diabetes are contributing to the rising incidence of CVD, such as stroke. Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, affecting over ~886,000 new people in Europe each year. According to the US Census Bureau report on the burden of atrial fibrillation, Europe is expected to register the highest number of patients with AF by 2050. So, the rising number of incidences of target diseases and procedures is expected to drive the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe electrophysiology market at a substantial CAGR during the forecast period.
Europe Electrophysiology Market Revenue and Forecast to 2028 (US$ Million)
Europe Electrophysiology Market Segmentation
The Europe electrophysiology market is segmented based on product, indication, and country. Based on product, the market is segmented into electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, access devices, and others. The electrophysiology laboratory devices segment dominated the market in 2022 and electrophysiology ablation catheters segment is expected to be fastest growing during forecast period. Based on indication, the market is segmented into atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and others. The atrial fibrillation (AF) segment dominated the market in 2022 and is expected to be fastest growing during forecast period. Based on country, the Europe electrophysiology market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.
Abbott; Biotronik, Inc.; Boston Scientific Corporation; CardioFocus; GE Healthcare; Johnson & Johnson Services, Inc.; Koninklijke Philips N.V.; Medtronic; MicroPort Scientific Corporation; and Siemens Healthineers AG are among the leading companies operating in the Europe electrophysiology market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe electrophysiology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe electrophysiology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the electrophysiology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution"
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook